US Patent Litigations are now available. Check here

Explore Biontech Cell&gene Therapies's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Jun 26, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3294325Jul 26, 2023Enhancing The Effect Of Car-Engineered T Cells By Means Of Nucleic Acid Vaccination1
EP3126381Feb 16, 2022Claudin-6-Specific Immunoreceptors And T Cell Epitopes1
EP3294333Sep 2, 2020Claudin-18.2-Specific Immunoreceptors And T Cell Epitopes1